Search Results - "Bouras, E. P."

Refine Results
  1. 1

    Review article: current treatment options and management of functional dyspepsia by Lacy, B. E., Talley, N. J., Locke III, G. R., Bouras, E. P., DiBaise, J. K., El-Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., Prather, C.

    Published in Alimentary pharmacology & therapeutics (01-07-2012)
    “…Summary Background Functional dyspepsia (FD), a common functional gastrointestinal disorder, is defined by the Rome III criteria as symptoms of epigastric pain…”
    Get full text
    Journal Article
  2. 2

    SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication by Bouras, E P, Delgado-Aros, S, Camilleri, M, Castillo, E J, Burton, D D, Thomforde, G M, Chial, H J

    Published in Gut (01-12-2002)
    “…Background: Impaired gastric accommodation may lead to dyspeptic symptoms. A non-invasive method using single photon emission computed tomography (SPECT) has…”
    Get full text
    Journal Article
  3. 3

    Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans by Bouras, E P, Camilleri, M, Burton, D D, McKinzie, S

    Published in Gut (01-05-1999)
    “…BACKGROUND Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chemical class of benzofurans, with gastrointestinal prokinetic…”
    Get full text
    Journal Article
  4. 4

    Successful oesophageal pH monitoring with a catheter‐free system by Ward, E. M., Devault, K. R., Bouras, E. P., Stark, M. E., Wolfsen, H. C., Davis, D. M., Nedrow, S. I., Achem, S. R.

    Published in Alimentary pharmacology & therapeutics (15-02-2004)
    “…Summary Background : Traditional catheter‐based oesophageal pH testing is limited by patient discomfort and the tendency for patients to alter their diet and…”
    Get full text
    Journal Article
  5. 5

    Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder by Bouras, Ernest P., Camilleri, Michael, Burton, Duane D., Thomforde, George, McKinzie, Sanna, Zinsmeister, Alan R.

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-2001)
    “…Background & Aims: Prucalopride (PRU) is a selective benzofuran 5-hydroxytryptamine4–receptor agonist with gastrointestinal and colonic prokinetic activities…”
    Get full text
    Journal Article
  6. 6

    Rational approach to patients with unintentional weight loss by Bouras, E P, Lange, S M, Scolapio, J S

    Published in Mayo Clinic proceedings (01-09-2001)
    “…Unintentional weight loss is a problem encountered frequently in clinical practice. Weight loss and low body weight have potentially serious clinical…”
    Get more information
    Journal Article
  7. 7

    Effect of cyclooxygenase‐2 inhibitors on gastric emptying and small intestinal transit in humans by Bouras, E. P., Burton, D. D., Camilleri, M., Stephens, D. A., Thomforde, G. M.

    Published in Neurogastroenterology and motility (01-12-2004)
    “…Endogenous prostaglandins regulate smooth muscle activity; prostaglandins and cyclooxygenase (COX) inhibitors influence gastrointestinal motility in…”
    Get full text
    Journal Article
  8. 8

    Nutritional Management of Chronic Intestinal Pseudo-Obstruction by Scolapio, J S, Ukleja, A, Bouras, E P, Romano, M

    Published in Journal of clinical gastroenterology (01-06-1999)
    “…Chronic intestinal pseudo-obstruction (CIP) is a gastrointestinal motility disturbance characterized by recurrent episodes of postprandial nausea and bloating…”
    Get full text
    Journal Article
  9. 9

    Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis by Onken, J E, Brazer, S R, Eisen, G M, Williams, D M, Bouras, E P, DeLong, E R, Long, 3rd, T T, Pancotto, F S, Rhodes, D L, Cotton, P B

    Published in The American journal of gastroenterology (01-04-1996)
    “…Accurate preoperative prediction of choledocholithiasis is essential in order to minimize patient risk and curtail health care expenditures. This study was…”
    Get more information
    Journal Article
  10. 10

    Inter-observer agreement for multichannel intraluminal impedance-pH testing by Ravi, K., DeVault, K. R., Murray, J. A., Bouras, E. P., Francis, D. L.

    Published in Diseases of the esophagus (01-09-2010)
    “…SUMMARY Twenty‐four‐hour ambulatory multichannel intraluminal impedance (MII)–pH detects both acid and nonacid reflux (NAR). A computer‐based program…”
    Get full text
    Journal Article
  11. 11

    Role of calcium in monitor peptide-stimulated cholecystokinin release from perifused intestinal cells by Bouras, E P, Misukonis, M A, Liddle, R A

    Published in The American journal of physiology (01-05-1992)
    “…Monitor peptide stimulates cholecystokinin (CCK) release from the intestine, but the cellular mechanisms responsible for this effect are uncertain. In the…”
    Get full text
    Journal Article
  12. 12

    Evidence for indirect dietary regulation of cholecystokinin release in rats by Sharara, A.I, Bouras, E.P, Misukonis, M.A, Liddle, R.A

    Published in The American journal of physiology (01-07-1993)
    “…Food ingestion stimulates cholecystokinin (CCK) release from the proximal intestine, but the mechanisms involved are not well understood. To investigate this…”
    Get full text
    Journal Article
  13. 13

    Cerebral topography of rectal stimulation using single photon emission computed tomography by Bouras, E P, O'Brien, T J, Camilleri, M, O'Connor, M K, Mullan, B P

    Published in The American journal of physiology (01-09-1999)
    “…Central processing of visceral information in humans is incompletely understood. We aimed to demonstrate the feasibility of single photon emission computed…”
    Get full text
    Journal Article
  14. 14

    Epidemiology and management of chronic constipation in elderly patients by Vazquez Roque, Maria, Bouras, Ernest P

    Published in Clinical interventions in aging (01-01-2015)
    “…Constipation is a common functional gastrointestinal disorder, with prevalence in the general population of approximately 20%. In the elderly population the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites by Aqel, Bashar A, Scolapio, James S, Dickson, Rolland C, Burton, Duane D, Bouras, Ernest P

    Published in Clinical gastroenterology and hepatology (01-11-2005)
    “…Protein calorie malnutrition and weight loss are common among patients with cirrhosis and ascites. The cause of these symptoms is unclear, with several…”
    Get more information
    Journal Article
  18. 18

    SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography by Bouras, E P, Delgado-Aros, S, Camilleri, M, Castillo, E J, Burton, D D, Thomforde, G M, Chial, H J

    Published in Gut (01-12-2002)
    “…Impaired gastric accommodation may lead to dyspeptic symptoms. A non-invasive method using single photon emission computed tomography (SPECT) has been…”
    Get full text
    Journal Article
  19. 19

    Selective stimulation of colonic transit by the benzofuran 5HT 4 agonist, prucalopride, in healthy humans by Bouras, E P, Camilleri, M, Burton, D D, McKinzie, S

    Published in Gut (01-05-1999)
    “…BACKGROUND Prucalopride (R093877) is a selective and specific 5HT 4 agonist, the first of a new chemical class of benzofurans, with gastrointestinal prokinetic…”
    Get full text
    Journal Article
  20. 20

    Superior mesenteric artery (Wilkie's) syndrome as a result of cardiac cachexia by Roy, Archana, Gisel, Justin J, Roy, Vivek, Bouras, Ernest P

    “…Superior mesenteric artery (SMA) syndrome is a rare acquired disorder in which acute angulation of SMA causes compression of the third part of the duodenum…”
    Get full text
    Journal Article